Write in a clean editor, then format for Journal of Clinical Rheumatology and Immunology in one click — DocuGuru applies the official World Scientific template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Clinical Rheumatology and Immunology is a peer-reviewed journal published by World Scientific, covering Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Spondyloarthritis Studies and Treatments.
| Publisher | World Scientific |
|---|---|
| Reference style | Superscript numbered (World Scientific) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Journal of Clinical Rheumatology and Immunology 12, 45–58 (2023).
Formats any DOI in the closest standard style — Journal of Clinical Rheumatology and Immunology has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Rheumatoid Arthritis Research and Therapies Systemic Lupus Erythematosus Research Spondyloarthritis Studies and Treatments Systemic Sclerosis and Related Diseases Vasculitis and related conditions |
| ISSN | 2661-3417 |
| Citation impact (2-yr) | 0.07 |
| h-index | 4 |
| Total citations | 103 |
| Article processing charge | $800 |
| Open access | Yes |
| Top institutions publishing here | Chinese University of Hong Kong |
| Journal website | www.worldscientific.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Manifestations of neuropsychiatric systemic lupus erythematosus (NPSLE) are heterogeneous. Acute psychosis is an uncommon but well-recognized manifestation of NPSLE. With no specific biomarkers to date, the diagnosis of NPSLE relies on clinical acumen for circumstantial evidence and exclusion of important differential diagnoses. The attribution of psychosis to NPSLE is facilitated by the application attribution models.…
Patients with immune-mediated inflammatory diseases on anti-tumor necrosis factor (TNF) agents are at increased risk of developing active tuberculosis (TB). Screening and treatment of latent tuberculosis infection (LTBI) with the use of a standard screening protocol is important in reducing the risk of TB reactivation during therapies with anti-TNF agents. The Latent Tuberculosis Infection Working…
Patients with autoimmune rheumatic diseases are potentially at risk of more serious Coronavirus Disease 2019 (COVID-19) infection and increased mortality due to immunosuppressive therapies and disease-related medical comorbidities. Uncertainty about the safety and efficacy of the COVID-19 vaccines is a major deterrent for patients to participate in the vaccination program. The Hong Kong Society of…
Allopurinol is an effective urate lowering agent but may lead to rare but life-threatening severe cutaneous adverse reactions (SCAR). Genetic predisposition, age, sex, renal function, dosage and concomitant diuretic use are known risk factors of allopurinol related SCAR. Among these factors, HLA-B[Formula: see text]58:01 confers the highest risk. Frequency of the HLA-B[Formula: see text]58:01 allele…
Osteoporosis and osteoporotic fracture are one of the most common side effects of glucocorticoid therapy. All patients who are taking any dose of glucocorticoids for over 3 months should have a bone health assessment. After consideration of their clinical risk factors, glucocorticoid dose, bone mineral density measurement, and the Fracture Risk Assessment Tool score, patients…
